Cargando…
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss: Miniperspective
[Image: see text] Cisplatin is a highly effective treatment for malignant cancers and has become a cornerstone in chemotherapeutic regimens. Unfortunately, its use in the clinic is often coupled with a high incidence of severe hearing loss. Over the past few decades, enormous effort has been put for...
Autores principales: | Hazlitt, Robert A., Min, Jaeki, Zuo, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043375/ https://www.ncbi.nlm.nih.gov/pubmed/29361217 http://dx.doi.org/10.1021/acs.jmedchem.7b01653 |
Ejemplares similares
-
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
por: Teitz, Tal, et al.
Publicado: (2018) -
Hydrocarbon-Stapled Peptides:
Principles, Practice,
and Progress: Miniperspective
por: Walensky, Loren D., et al.
Publicado: (2014) -
Development of Synthetic Lethality
Anticancer Therapeutics: Miniperspective
por: Fang, Bingliang
Publicado: (2014) -
Development of
Safe and Effective Botanical Dietary Supplements: Miniperspective
por: van Breemen, Richard B.
Publicado: (2015) -
The Essential Medicinal
Chemistry of Curcumin: Miniperspective
por: Nelson, Kathryn M., et al.
Publicado: (2017)